tiprankstipranks
Dynavax sees Q4 HEPLISAV-B vaccine net product revenue about $51M
The Fly

Dynavax sees Q4 HEPLISAV-B vaccine net product revenue about $51M

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles